We're also collaborating with Merck KGaA to evaluate NKTR-255 in combination with BAVENCIO for bladder cancer with the first ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in ...

In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Inc. is a late-stage clinical biopharmaceutical company dedicated to developing bladder-sparing therapies for bladder cancer patients, with a focus on innovative immunotherapies. CG Oncology recently ...

Pfizer topped estimates and hiked its full year guidance. Cancer drugs brought in $854 million to Pfizer’s revenue table, ...

The promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients. “The goal is to ...

Eric Braeden has been part of The Young and the Restless since 1980. He admitted that he doesn't plan on hanging up the role ...

Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...

When John noticed blood in his urine, he consulted his doctor and was quickly referred to a urologist. (John is a composite character, based on the experiences of real-life patients.) John was ...

Urogen's UGN-102 presents a $5B market opportunity for bladder cancer treatment, despite risks. Read more about URGN stock ...